$69.9B
$662,000
5.08% of portfolio
4,321
Q1 2025
Added 35.33%
$309B
$651,000
4.99% of portfolio
2,441
Q1 2025
Added 15.47%
$165B
$631,000
4.84% of portfolio
2,230
Q1 2025
Added 4.25%
$112B
$617,000
4.73% of portfolio
2,530
Q1 2025
Added 40.09%
$100B
$615,000
4.72% of portfolio
1,782
Q1 2025
Added 68.91%
$50.9B
$612,000
4.69% of portfolio
3,138
Q1 2025
Added 36.32%
$570B
$596,000
4.57% of portfolio
1,701
Q1 2025
Added 29.65%
$79.9B
$580,000
4.45% of portfolio
420
Q1 2025
Added 23.17%
$97.2B
$571,000
4.38% of portfolio
5,108
Q1 2025
Added 98.21%
$535B
$559,000
4.29% of portfolio
1,020
Q1 2025
Added 26.08%
$379B
$555,000
4.26% of portfolio
1,060
Q1 2025
Added 68.52%
$741B
$553,000
4.24% of portfolio
2,258
Q1 2025
Added 13.13%
$449B
$550,000
4.22% of portfolio
582
Q1 2025
Added 10.44%
$130B
$530,000
4.06% of portfolio
7,488
Q1 2025
Added 103.81%
$29.4B
$525,000
4.03% of portfolio
2,450
Q1 2025
Added 26.75%
$79.2B
$514,000
3.94% of portfolio
846
Q1 2025
Added 39.6%
$370B
$504,000
3.87% of portfolio
1,377
Q1 2025
Added 38.67%
$168B
$504,000
3.87% of portfolio
4,480
Q1 2025
Added 31.19%
$3.25T
$480,000
3.68% of portfolio
1,280
Q1 2025
Added 40.66%
$144B
$477,000
3.66% of portfolio
2,331
Q1 2025
Added 59.22%
$1.9T
$458,000
3.51% of portfolio
2,411
Q1 2025
Added 6.12%
$1.01T
$439,000
3.37% of portfolio
2,811
Q1 2025
Added 14.45%
$284B
$420,000
3.22% of portfolio
3,884
Q1 2025
Reduced 23.78%
$140B
$287,000
2.2% of portfolio
2,427
Q1 2025
New
$60.3B
$67,000
0.51% of portfolio
12,252
Q1 2025
New
$25B
$42,000
0.32% of portfolio
19,173
Q1 2025
Added 26.08%
$230M
$41,000
0.31% of portfolio
30,412
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
New
Translational Dev Acquisitio
-
$0
0.0% of portfolio
-
Q4 2024
New
Range Cap Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 66.67%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 66.67%
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 75.0%
Willow Lane Acquisition Corp
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 77.78%
Newhold Investment Iii Unt
-
$0
0.0% of portfolio
-
Q1 2025
New
Gesher Acquisition Ii Unt
-
$0
0.0% of portfolio
-
Q1 2025
New
Future Vision Ii Acquisition
-
$0
0.0% of portfolio
-
Q3 2024
New
Eqv Ventures Acquisition Cor
-
$0
0.0% of portfolio
-
Q4 2024
New
Drugs Made In America Acquisitn Unt
-
$0
0.0% of portfolio
-
Q1 2025
New
Colombier Acquisition Corp I
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 19.9%
Cohen Circle Acquisition Cor
-
$0
0.0% of portfolio
-
Q1 2025
Reduced 21.43%
Chenghe Acquisition Ii CO
-
$0
0.0% of portfolio
-
Q3 2024
New
Canadian Pacific Kansas City
-
$0
0.0% of portfolio
-
Q1 2025
Added 68.22%
Archimedes Tech Spac Partners Ii Unt
-
$0
0.0% of portfolio
-
Q1 2025
New
-
$0
0.0% of portfolio
-
Q4 2024
New
-
$0
0.0% of portfolio
-
Q3 2024
New
Newbury Str Ii Acquisition C
-
$0
0.0% of portfolio
-
Q4 2024
New
Mountain Lake Acquisition CO
-
$0
0.0% of portfolio
-
Q4 2024
New